Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Indegene

INDGN
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Indegene Share price and Fundamental Analysis

View All Details
View All Details
Indegene Ltd was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited' and a fresh certificate of incorporation was issued to Company by RoC, on November 17, 2022.
Company Incorporation1998
ChairmanNA
Head QuartersNA
Previous NameIndegene Pvt Ltd

Key Metrics

Market Cap (Cr)
14,017
PE Ratio
33.65
Industry P/E
47.05
PEG Ratio
0
ROE
15.55%
ROCE
20.54%
ROA
12.23%
Total Debt (Cr)
101.6
Debt to Equity
0.04
Dividend Yield
0.34%
EPS
17.35
Book Value & P/B
108.92 x 5.36
Face Value
2
Outstanding Shares(Cr)
24.01
Current Ratio
4.73
EV to Sales
4.84

Included In

+More

Stock Returns

1 Week+0.92%
1 Month+9.38%
6 Months-3.98%
1 Year+9.69%
3 Years+4.34%
5 Years+4.34%

CAGR

1 Year CAGR

Revenue Growth

+9.64%

Net Profit Growth

+20.79%

Operating Profit Growth

+9.83%

Dividend Growth

N/A

Stock Returns CAGR

+7.09%
no_data

No Stocks

Smart Score

2.7
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 0.00%

FIIs : 5.24%

DIIs : 4.96%

Public : 89.80%

Promoter
FII/FPI
DII
Public
FII Shareholding Increased by 0.21% to 5.24% in March 2025 Qtr
DII Shareholding Increased by 0.98% to 4.96% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Indegene Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Indegene Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Indegene Ltd was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited' and a fresh certificate of incorporation was issued to Company by RoC, on November 17, 2022.

The Company is a 'digital-first' commercialization company focused exclusively on the global life sciences industry. Their solutions enable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. Their portfolio of solutions cover all aspects of commercial, medical, regulatory and R&D operations of life sciences companies.

Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a 'digital first' approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.

Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analytics in helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.

In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies.

In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.

On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.

The Company acquired Cult Health, a full-service healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.

The Company is planning to raise capital from Public by raising Rs 950 crores through fresh issue and 36,291,497 Equity Shares through Offer For Sale.

Indegene Share Price

Indegene share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Indegene Market Cap

Market capitalization of Indegene indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Indegene is valued compared to its competitors.

Indegene PE Ratio

Indegene PE ratio helps investors understand what is the market value of each stock compared to Indegene 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Indegene PEG Ratio

The PEG ratio of Indegene evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Indegene ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Indegene generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Indegene ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Indegene in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Indegene Total Debt

Total debt of Indegene shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Indegene Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Indegene compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Indegene CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Indegene over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Indegene Technical Analysis

Technical analysis of Indegene helps investors get an insight into when they can enter or exit the stock. Key components of Indegene Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Indegene shares often struggle to rise above due to selling pressure.

Indegene Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Indegene ’s financial health and profitability.

Indegene Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Indegene Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Indegene Financials

The financials of Indegene provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Indegene Profit and Loss Statements

The profit and loss statement of Indegene highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Indegene .

Indegene Balance Sheet

The balance sheet presents a snapshot of Indegene ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Indegene Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App